Form 4 for PRVA Privia Health Group, Inc.

Accepted 2022-11-22 00:00:00 ET · period of report 2022-11-21 · accession 0000895345-22-000790 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
I	2022-11-22	2022-11-21	PRVA	BERNSTEIN JEFFREY DANIEL	Dir	S - Sale	$22.56	-3.19M	24.83M	-11%	-$71.90M

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-11-21	S	D	3,186,888	$22.56	24,826,071	I See footnotes	—	—	(F3) As of November 21, 2022, as a result of the Offering, GS Group and Goldman Sachs may be deemed to beneficially own indirectly 24,826,071 shares of Common Stock by reason of Common Stock held by certain investment entities (the "GS Funds") of which Goldman Sachs and GS Group are the general partner, managing limited partner, managing general partner, managing partner, managing member or member. (F1) The Reporting Person is a managing director of Goldman Sachs & Co. LLC ("Goldman Sachs"). Goldman Sachs is a subsidiary of The Goldman Sachs Group, Inc. ("GS Group"). The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein, if any. (F2) Pursuant to an underwriting agreement, dated November 16, 2022 (the "Underwriting Agreement"), the GS Funds (as defined below) offered and sold an aggregate 3,186,888 shares of Common Stock as set forth in the final prospectus filed by the Issuer on November 18, 2022, which offering was consummated on November 21, 2022 (the "Offering"). The amount above represents the $23.50 public offering price per share of Common Stock in the Offering less the underwriting discount of $0.94 per share of Common Stock.